National Health (Listed drugs on F1 or F2) Amendment Determination 2012 (No. 3) (No. PB 30 of 2012)

Link to law: https://www.comlaw.gov.au/Details/F2012L01074

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now
 
National Health (Listed drugs on F1 or F2) Amendment Determination 2012 (No.3)
Instrument number PB 30 of 2012
National Health Act 1953
I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the
Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.
Dated                      23  May   2012
 
 
 
 
 
 
 
 
 
ADRIANA PLATONA
 
Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health and Ageing
 
 
Part 1         Preliminary
1              Name of Determination
         (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2012 (No.3).
         (2)   This Determination may also be cited as PB 30 of 2012.
2              Commencement
                This Determination commences on 1 June 2012.
3              Amendment of National Health (Listed drugs on F1 or F2) Determination 2010
                Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).
Schedule 1             Amendments
 
(Section 3)
 
 
[1]     Schedule 2, after item dealing with Amlodipine
 
Insert
 
Amlodipine with Atorvastatin 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note
1.       All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See http://www.frli.gov.au.